Company press releases
Tid | Selskap | Tittel | Sektor | Kategori |
---|---|---|---|---|
25 Oct 2024 08:00 CEST |
AF GRUPPEN | Nominated for assignment at the New Aker hospital | 50101010 Construction | Non-regulatory press releases |
25 Oct 2024 08:00 CEST |
WERELDHAVE BELGIUM | Trading update 30 septembre 2024 | 35102045 Retail REITs | New |
25 Oct 2024 08:00 CEST |
GOODTECH | A quarter in between larger projects for Goodtech | 50202030 Electronic Equipment: Pollution Control | Half yearly financial reports and audit reports/limited reviews |
25 Oct 2024 08:00 CEST |
RENAULT | Mise en oeuvre du programme de rachat d’actions | 40101020 Automobiles | Other subject |
25 Oct 2024 08:00 CEST |
Kraft Bank ASA | 3K24 Økt lønnsomhet | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
25 Oct 2024 08:00 CEST |
ATOS | US District Court for the Southern District of New York orders a new trial on compensatory damages in Atos’ litigation with TriZetto | 10101010 Computer Services | Legal |
25 Oct 2024 08:00 CEST |
Acheter-Louer.fr | Communiqué de presse du 25/10/24 : "Nombre d’actions de la Société soumises aux opérations de regroupement et montant définitif de la réduction du capital" | 10101020 Consumer Digital Services | Legal |
25 Oct 2024 08:00 CEST |
WERELDHAVE BELGIUM | Trading update 30 september 2024 | 35102045 Retail REITs | New |
25 Oct 2024 08:00 CEST |
AF GRUPPEN | Innstilt til oppdrag på Nye Aker sykehus | 50101010 Construction | Ikke-informasjonspliktige pressemeldinger |
25 Oct 2024 08:00 CEST |
WERELDHAVE BELGIUM | Trading update 30 September 2024 | 35102045 Retail REITs | New |
25 Oct 2024 07:58 CEST |
Elkem ASA | Finansiell kalender | 55201000 Chemicals: Diversified | Annen informasjonspliktig regulatorisk informasjon |
25 Oct 2024 07:58 CEST |
Elkem ASA | Financial calendar | 55201000 Chemicals: Diversified | Additional regulated information required to be disclosed under the laws of a Member State |
25 Oct 2024 07:30 CEST |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
25 Oct 2024 07:30 CEST |
NORSK TITANIUM AS | Invitation to presentation of third quarter operational and financial Update | 55102015 Metal Fabricating | Non-regulatory press releases |
25 Oct 2024 07:30 CEST |
REMY COINTREAU | Rémy Cointreau : Chiffre d’affaires en baisse de -16,1% en organique1 au T2 2024-25 | 45101015 Distillers and Vintners | Other subject |
25 Oct 2024 07:30 CEST |
SANOFI | Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance | 20103015 Pharmaceuticals | Other subject |
25 Oct 2024 07:30 CEST |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
25 Oct 2024 07:30 CEST |
REMY COINTREAU | Rémy Cointreau: Sales Down -16.1% in Organic Terms1 in Q2 2024-25 | 45101015 Distillers and Vintners | Other subject |
25 Oct 2024 07:30 CEST |
SANOFI | Communiqué de presse : T3 2024 : Croissance des ventes de 15,7% soutenue par une séquence des ventes de vaccins plus favorable qu’anticipée; Sanofi relève ses perspectives de BNPA des activités 2024 suite à la forte performance | 20103015 Pharmaceuticals | Other subject |
25 Oct 2024 07:02 CEST |
SIGNIFY NV | Signify proposes appointment of CFO Zeljko Kosanovic to Board of Management | 50101035 Building Materials: Other | Other subject |
25 Oct 2024 07:00 CEST |
KOMPLETT ASA | Q3-24: Results impacted by weak trading environment, but with tangible signs of easing headwinds | 40401030 Specialty Retailers | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
25 Oct 2024 07:00 CEST |
KOMPLETT ASA | Q3-24: Resultatene påvirkes av et fortsatt svakt marked, men med tegn til bedring | 40401030 Specialty Retailers | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
25 Oct 2024 07:00 CEST |
Schibsted ASA | Schibsted ASA (SCHA/SCHB) - Interim Report Q3 2024 | 10101020 Consumer Digital Services | Half yearly financial reports and audit reports/limited reviews |
25 Oct 2024 07:00 CEST |
SAFRAN | Safran - Révision à la hausse de la profitabilité pour 2024 | 50201010 Aerospace | Share history |
25 Oct 2024 07:00 CEST |
SIGNIFY NV | Signify reports third quarter sales of EUR 1.5 billion, operational profitability of 10.5% and a free cash flow of EUR 119 million | 50101035 Building Materials: Other | Income |
25 Oct 2024 07:00 CEST |
SAFRAN | Safran - Full-year outlook profit raised | 50201010 Aerospace | Share history |
25 Oct 2024 07:00 CEST |
WERELDHAVE Gewone aandelen | Wereldhave Trading update Q3 2024 | 35102045 Retail REITs | Commercial results |
25 Oct 2024 07:00 CEST |
Norwegian Air Shuttle ASA | The Norwegian Group with solid third quarter results | 40501010 Airlines | Half yearly financial reports and audit reports/limited reviews |
25 Oct 2024 06:45 CEST |
TINC | TINC Announces a Strategic Partnership for Datacenter United and the Acquisition of the Data Centres of Proximus (B) | 30202010 Asset Managers and Custodians | Other subject |
25 Oct 2024 06:45 CEST |
TINC | TINC kondigt een Strategisch Partnerschap aan voor Datacenter United en de overname van de Datacenters van Proximus (B) | 30202010 Asset Managers and Custodians | Other subject |
25 Oct 2024 06:45 CEST |
TINC | TINC Announces a Strategic Partnership for Datacenter United and the Acquisition of the Data Centres of Proximus (B) | 30202010 Asset Managers and Custodians | Other subject |
24 Oct 2024 23:30 CEST |
NYRSTAR | Nyrstar NV provides an update with regards to the Mechelen criminal investigation | 55102050 Nonferrous Metals | Other subject |
24 Oct 2024 23:30 CEST |
NYRSTAR | Nyrstar NV geeft een update met betrekking tot het gerechtelijk onderzoek in Mechelen | 55102050 Nonferrous Metals | Other subject |
24 Oct 2024 22:06 CEST |
TERACT S.A. | TERACT - Mise à disposition du Document d’enregistrement universel 2023-2024 | 40401010 Diversified Retailers | Income |
24 Oct 2024 22:06 CEST |
TERACT S.A. | TERACT - Availability of the 2023-2024 Universal Registration Document | 40401010 Diversified Retailers | Income |
24 Oct 2024 21:30 CEST |
NORDEA BANK | Nordea Bank Abp: Repurchase of own shares on 24.10.2024 | 30101010 Banks | Acquisition or disposal of the issuer’s own shares |
24 Oct 2024 21:08 CEST |
GENSIGHT BIOLOGICS | GenSight Biologics publie sa situation nette de trésorerie au 30 septembre 2024, et fait un point sur ses activités | 20103010 Biotechnology | Other financial transaction |
24 Oct 2024 21:08 CEST |
GENSIGHT BIOLOGICS | GenSight Biologics Reports Cash Position as of September 30, 2024, and Provides Business Update | 20103010 Biotechnology | Other financial transaction |
24 Oct 2024 20:48 CEST |
NHOA | NHOA : Mise à jour commerciale et opérationnelle T3 2024 | 60102020 Renewable Energy Equipment | Other subject |
24 Oct 2024 20:48 CEST |
NHOA | NHOA: Q3 2024 Trading and Operational Update | 60102020 Renewable Energy Equipment | Other subject |
24 Oct 2024 19:52 CEST |
TIKEHAU CAPITAL | Tikehau Capital: Disclosure of Shares Repurchases From 18 October 2024 to 24 October 2024 | 30202010 Asset Managers and Custodians | Other subject |
24 Oct 2024 19:52 CEST |
TIKEHAU CAPITAL | Tikehau Capital : Déclaration des transactions sur actions propres réalisées du 18 octobre 2024 au 24 octobre 2024 | 30202010 Asset Managers and Custodians | Other subject |
24 Oct 2024 19:40 CEST |
FNAC DARTY | Fnac Darty/Unieuro : Waiver antitrust / Significant part of the capital tendered to date | 40401030 Specialty Retailers | Takeover bids |
24 Oct 2024 19:40 CEST |
FNAC DARTY | Fnac Darty/Unieuro : Waiver antitrust / Une part significative du capital apporté à ce jour | 40401030 Specialty Retailers | Takeover bids |
24 Oct 2024 19:30 CEST |
ABIONYX PHARMA | Les résultats cliniques de l'étude RACERS d'ABIONYX Pharma sur le brouillard cérébral sélectionnés pour la présentation d'un poster au congrès annuel 2024 de l'American Society of Nephrology (ASN) « Kidney Week » | 20103010 Biotechnology | Other subject |
24 Oct 2024 19:30 CEST |
ABIONYX PHARMA | ABIONYX Pharma RACERS Study Clinical Results in Brain-Fog Selected for Poster Presentation at the American Society of Nephrology (ASN) 2024 Annual Meeting "Kidney Week" | 20103010 Biotechnology | Other subject |
24 Oct 2024 19:20 CEST |
FRANCAISE ENERGIE | Chiffre d'affaires de 7,1 M EUR au premier trimestre 2025 (en intégration globale ) | 65101010 Alternative Electricity | Sales, Income, Commercial results |
24 Oct 2024 19:20 CEST |
FRANCAISE ENERGIE | Revenues of EUR 7.1 million in Q1 2025 (full consolidation) | 65101010 Alternative Electricity | Sales, Income, Commercial results |
24 Oct 2024 19:06 CEST |
ICADE | ICADE - Avenant au contrat de liquidité | 35102030 Office REITs | Other subject |
24 Oct 2024 18:49 CEST |
SHELL PLC | Transaction in Own Shares | 60101000 Integrated Oil and Gas | Other subject |